Tadeusz Robak
Researcher Next ID · RN-009165
Researcher · Medicine
, Poland
- Works count
- 1,219
- Citation count
- 38,049
- H-index
- 81
- i10-index
- 483
Research interests
Publications
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
Blood · 2018 · 10.1182/blood-2017-09-806398
Venetoclax–Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia
New England Journal of Medicine · 2018 · 10.1056/nejmoa1713976
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
New England Journal of Medicine · 2015 · 10.1056/nejmoa1509388
Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
New England Journal of Medicine · 2014 · 10.1056/nejmoa1400376
Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study
The Lancet Oncology · 2011 · 10.1016/s1470-2045(11)70081-x
Current projects
No projects listed.